Home » Clinical Trials » Alzheimer's Disease

Trial Information

Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease

Official Title: A Phase II, Double Blind, Placebo-controlled, Randomized, Multi-Center, Parallel Group Dose Exploring Study to Evaluate the Efficacy and Safety of Octohydroaminoacridine Succinate Tablets in Patient With Mild to Moderate Alzheimer's Disease

Summary

The main purpose of this study is to evaluate the safety and efficacy of Octohydroaminoacridine Succinate tablets and find the optimal dose in patients with mild to moderate Alzheimer's Disease.

Phase: Phase 2

Sponsor: Changchun Huayang High-tech Co., Ltd

Overall Contacts:

Huafang Li, MD
86-21-64387250 ext. 3128
lhlh5@yahoo.com.cn

Locations (13)

Country	State	City	Zip	Facility and Contact
China	Guangdong	Guangzhou		Guangzhou Brain Hospital Hui Li 86-20-81898313 Muni Tang, MD Principal Investigator
China	Guangxi	Guilin		Affiliated Hospital of Guilin Medical University Wei Chen 86-13737710329 glfyli@163.com Kaixiang Liu Principal Investigator
China	Hebei	Baoding		Hebei mental health center Qinpu Jiang JiangQinpu@yahoo.cn Qinpu Jiang Principal Investigator
China	Jiangsu	Nanjing		Jiangsu Province Hospital Tianping Li 86-25-68136221 jsphkj@163.com Weixian Chen Principal Investigator
China	Jilin	Changchun		The first Affiliated Hospital of Jilin University Fei Wang 13500815780 Li Sun, MD Principal Investigator
China	Yunnan	Kunming		First Affiliated Hospital of Kunming Medical University Jian Qin qinjian3337@sina.com Yan Bai Principal Investigator
China	Zhejiang	Hangzhou		The First Affiliated Hospital of Medical School of Zhejiang University Benyan Luo luobenyan@zju.edu.cn Benyan Luo Principal Investigator
China		Beijing		Beijing HuiLongGuan Hospital Guanghui Zhang zhgh1998@126.com Lan Shang Principal Investigator
China		Beijing		Beijing Shijitan Hospital, EMU Shumei Wang 13811830809@126.com Jing Zhang Principal Investigator
China		Shanghai		Shanghai Tenth People's hospital Jie Yu Xueyuan Liu Principal Investigator
China		Shanghai		Shanghai First People's Hospital Xiaohua Li 86-21-63240090 ext. 6410 Xiaoping Wang Principal Investigator
China		Shanghai		Shanghai Huafang Li 86-21-64387250 ext. 3128 Lhly5@yahoo.com.cn Shifu Xiao, MD Principal Investigator Xia Li, MD Sub-Investigator
China		Shanghai		Shanghai Changzheng Hospital Zhongxin Zhao, MD zhaozx@medmail.com Zhongxin Zhao, MD Principal Investigator Liuqing Huang Sub-Investigator

NCT ID:NCT01569516

Date Last Changed: April 6, 2012